Admission Date: [**2129-9-30**]        Discharge Date: [**2129-10-9**]  Date of Birth:  [**2129-9-30**]        Sex:  M  Service:  NEONATOLOGY  HISTORY OF PRESENT ILLNESS:  [**Location (un) **] is a 2.845 kg baby boy delivered at 35 weeks gestation to a 34 year old gravida 2, now para 2 mother who was admitted to the [**Name (NI) **] Intensive Care Unit for management of hyperbilirubinemia, secondary to RH isoimmunization.
During labor there was no maternal fever but in light of the Group B Streptococcus positive status, the mother did receive one dose of antibiotics prior to delivery.
A cord blood sample was sent for bilirubin and noted to have a value of 5.4 mg/dl.
The baby therefore was admitted to the [**Name (NI) **] Intensive Care Unit for further management.
Fluids, electrolytes and nutrition - The baby has been fed ad lib breastfeeding and supplemented with Similac 20 calorie.
The baby was started upon admission on double phototherapy, this increased to quadruple phototherapy in the first day of life.
5 when the bilirubin was noted to be 7.7, and phototherapy was decreased to double phototherapy at that time.
The baby has been off of phototherapy for 48 hours prior to discharge with a rebound bilirubin on [**10-9**], of 11.0/0.4/10.6; this was stable over that period.
The baby had an initial dose of intravenous immunoglobulin in the first day of life at 750 mg/kg intravenously and had a second dose administered on day of life No.
A repeat hematocrit following the second dose of intravenous immunoglobulin showed virtually no change with a hematocrit of 34.8 and a recheck of 9 percent at that time.
The baby was started on iron at that time as well, 0.25 ml by mouth each day.
Infectious disease - There were no risk factors for sepsis, in light of the intrapartum antimicrobial prophylaxis for the maternal Group B Streptococcus colonization in the setting of a well-appearing baby.
Medications - Ferrous Sulfate 0.25 ml by mouth each day.
Immunizations received - Hepatitis B vaccine on [**10-7**].
Synagis respiratory syncytial virus prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria, I.
Influenza Immunization is recommended annually in the fall for all infants once they reach six months of age, before this age and for the first 24 months of the child's life immunization against influenza is recommended for household contacts and out of home caregivers.
Follow up appointments - With primary pediatrician, follow up bilirubin should be done the day following discharge.
